DMD and Duchenne muscular dystrophy: The use of CRISPR/Cas9 for DMD would involve editing the dystrophin gene in somatic cells, theoretically eliminating the risk of transmitting edited genes to offspring.32However, even somatic gene editing raises significant ethical considerations.